Daniel D. Pinschewer
Founder at Hookipa Biotech AG
Network origin in Daniel D. Pinschewer first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Biotechnology | 24 | |
University of Geneva
22
| College/University | Other Consumer Services | 22 |
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria.
19
| Subsidiary | Medical Specialties | 19 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Daniel D. Pinschewer via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Operating Officer | |
Schroder Investment Management Ltd.
Schroder Investment Management Ltd. Investment ManagersFinance Schroder Investment Management Ltd. (SIM) is the wholly-owned asset management subsidiary of Schroder International Holdings Ltd., ultimately held by Great Britain-based Schroders Plc (LSE: SDR, ADR: SHNWY). Established in 1985, SIM is headquartered in London and caters to a range of clients such as corporations, insurance firms, local and public authorities, charities, pension funds, high net-worth individuals and retail investors. | Investment Managers | Analyst-Equity | |
ICON PUBLIC LIMITED COMPANY | Miscellaneous Commercial Services | Director/Board Member | |
GeoVax, Inc.
GeoVax, Inc. BiotechnologyHealth Technology Part of GeoVax Labs, Inc., GeoVax, Inc. develops biotechnology and vaccines. The company is based in Smyrna, GA. GeoVax was acquired by Dauphin Technology, Inc. on October 03, 2006. The company was founded in 2001 by Harriet Latham Robinson. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Sanofi Pasteur, Inc.
Sanofi Pasteur, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Pasteur, Inc. provides vaccines for the prevention and treatment of diseases. It develops and manufactures influenza vaccine against the pandemic influenza virus. The company was founded in 1897 and is headquartered in Swiftwater, PA. | Pharmaceuticals: Major | President Chief Tech/Sci/R&D Officer | |
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Biotechnology | Public Communications Contact | |
BANQUE CANTONALE DE GENÈVE SA | Major Banks | Director/Board Member | |
Dunbar Capital Management LLC
Dunbar Capital Management LLC Investment ManagersFinance Part of Dunbar Capital Investors LLC, Dunbar Capital Management LLC is a company based in Whippany, NJ. | Investment Managers | Corporate Officer/Principal | |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Investment Banks/Brokers | Corporate Officer/Principal | |
ILC Dover LP
ILC Dover LP Pharmaceuticals: MajorHealth Technology ILC Dover LP operates as an engineering development and manufacturing company, which specializes in the use of flexible materials, serving the aerospace, personal protection, and pharmaceutical industries. Its products include lighter-than-air structures, personal protection equipment, engineered inflatables, powder containment, industrial containment, space suites, space inflatables, and specialty materials. The company was founded in 1947 and is headquartered in Federica, DE. | Pharmaceuticals: Major | Director/Board Member | |
Carson Group, Inc. (New York)
Carson Group, Inc. (New York) Investment ManagersFinance Carson Group provides financial information services. The firm specializes in global shareholder research and related advisory services. The company was foundedd by David M. Geliebter and is headquartered in New York, NY. | Investment Managers | Corporate Officer/Principal | |
Vassar College | College/University | Undergraduate Degree | |
University of Vienna | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
University College Dublin | College/University | Masters Business Admin | |
Trinity College Dublin | College/University | Undergraduate Degree | |
DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member | |
University of Basel | College/University | Doctorate Degree Graduate Degree | |
University College Cork | College/University | Corporate Officer/Principal | |
University of Tehran | College/University | Graduate Degree | |
Fondation Mérieux | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Crescendo Biologics Ltd.
Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Institute of Directors In Ireland
Institute of Directors In Ireland Miscellaneous Commercial ServicesCommercial Services Institute of Directors In Ireland promotes governance and develops leadership skills. It offer services to boards in Ireland including a non-executive director and chairperson appointment service through the boardroom centre, a board evaluation service, carried out by highly experienced assessors. The company is headquartered in Dublin, Ireland. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Advancion Corp.
Advancion Corp. Chemicals: SpecialtyProcess Industries Advancion develops and delivers distinct nitro alkane and derivatives. Its markets include paints and coatings, metalworking fluids, water treatment, personal care, life sciences, wood adhesives, leather tanning, synthesis, and synthetic rubber. The company was founded in 1936 and is headquartered in Buffalo Grove, IL. | Chemicals: Specialty | Director/Board Member | |
Institut de hautes études internationales et du développement | College/University | Graduate Degree | |
American Chamber of Commerce Ireland
American Chamber of Commerce Ireland Miscellaneous Commercial ServicesCommercial Services The American Chamber of Commerce Ireland is a leading international business organization that supports the Transatlantic business relationship. The non-profit company is based in Dublin, Ireland. The Irish company provides networking opportunities, leadership development programs, and representation to government, media, and stakeholders. The company's highly sought-after programs operate virtually and in person, supporting individual growth within their member companies. The CEO of the company is Mark Redmond. | Miscellaneous Commercial Services | Director/Board Member | |
National Institute for Bioprocessing Research & Training
National Institute for Bioprocessing Research & Training BiotechnologyHealth Technology The National Institute for Bioprocessing Research & Training (NIBRT) is a center of excellence for training and research in biopharmaceutical manufacturing. NIBRT operates in a world-class facility in Ireland, purpose-built to closely replicate a modern bioprocessing plant with state-of-the-art equipment. NIBRT offers the highest quality training and research solutions to support the growth and development of the biopharma manufacturing industry. | Biotechnology | Director/Board Member | |
Eyevensys SAS
Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Director/Board Member | |
UNIQURE N.V. | Biotechnology | Chief Executive Officer Founder | |
ACTINIUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Investor Relations Contact | |
NASDAQ
NASDAQ Investment Banks/BrokersFinance Part of Nasdaq, Inc., NASDAQ is a stock exchange. | Investment Banks/Brokers | Corporate Officer/Principal | |
Alexion Pharma International Operations Ltd.
Alexion Pharma International Operations Ltd. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Alexion Pharma International Operations Ltd. wholesales drugs, proprietaries and sundries. The company is based in Dublin, Ireland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
National Standards Authority of Ireland | Chairman | ||
Gilead Sciences Ireland UC | Chief Operating Officer | ||
The Guardian Ltd. (TZ) | Corporate Officer/Principal | ||
EXPRES2ION BIOTECH HOLDING AB | Biotechnology | Chief Tech/Sci/R&D Officer | |
Cardior Pharmaceuticals GmbH
Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Carasso Bossert SA | Director/Board Member | ||
Lian Capital Partners SA
Lian Capital Partners SA Investment ManagersFinance Lian Capital Partners SA (Lian Group) is a private equity/venture capital firm founded in 2017 by Fiorenzo Manganiello and Nessim-Sariel Gaon. The firm is headquartered in Luxembourg with additional offices in Dubai, Milan, Geneva, Tel Aviv, San Francisco and Zurich. | Investment Managers | Private Equity Investor Private Equity Investor | |
GeneSpire Srl
GeneSpire Srl BiotechnologyHealth Technology GeneSpire Srl is a holding company, which engages in the development of transformative gene therapies for patients with genetic diseases. The company was founded by Luigi Naldini and Alessio Cantone in March 2020 and is headquartered in Milan, Italy. | Biotechnology | Chairman Director/Board Member | |
ACHILLES THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
VAXXINITY, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Responsive Bioservices LLC | Chief Executive Officer | ||
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor |
Statistics
International
United States | 19 |
Ireland | 11 |
Switzerland | 7 |
United Kingdom | 4 |
France | 4 |
Sectoral
Health Technology | 18 |
Finance | 11 |
Consumer Services | 9 |
Commercial Services | 8 |
Miscellaneous | 2 |
Operational
Director/Board Member | 148 |
Corporate Officer/Principal | 82 |
Undergraduate Degree | 33 |
Graduate Degree | 28 |
Independent Dir/Board Member | 23 |
Most connected contacts
Insiders | |
---|---|
Graziano Seghezzi | 26 |
Michael Kelly | 19 |
Sander J. van Deventer | 17 |
Julie O'Neill | 16 |
Christoph S. Lengauer | 16 |
Jörn Aldag | 15 |
Jan van de Winkel | 15 |
Markus Hosang | 15 |
Graeme Martin | 15 |
John A. Lambert | 13 |
Erich Sieber | 13 |
Alex Cahana | 12 |
Victor Paulus | 12 |
Frank Kalkbrenner | 11 |
Marie Noëlle Venturi-Zen-Ruffinen | 11 |
- Stock Market
- Insiders
- Daniel D. Pinschewer
- Company connections